Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 1998View

Phase II Trial of Paclitaxel in Patients with Soft-Tissue Sarcoma

View Full Paper
Ask AI
Bookmark
Share

Authors

ECEphraim S. CasperValley Health SystemRWRoger J. WaltzmanAmicus Therapeutics (United States)GSGary K. SchwartzRutgers, The State University of New Jersey

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Casper et al. (1998) studied this question.

synapsesocial.com/papers/6a704571e5469ee92be10318https://doi.org/10.3109/07357909809011697
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas.1987 · 300 citations
  2. 2Phase II Study of Taxol in Patients With Untreated Advanced Non-Small-Cell Lung Cancer1993 · 431 citations
  3. 3Taxol: A Unique Antineoplastic Agent with Significant Activity in Advanced Ovarian Epithelial Neoplasms1989 · 1,113 citations
  4. 4Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma.1989 · 242 citations